To view or add a comment, sign in Genentech Reports the US FDA's Approval of Gazyva (Obinutuzumab) to Treat Lupus Nephritis #genentech #gazyva #obinutuzumab #lupusnephritis #usfda #regulatory #monoclonalantibody #nobility #regency #pii #piii #ro5072759 #rg7159 #r7159 #ga101 To view or add a comment, sign in Potential future royalty income from Metsera/Pfizer* obesity drug candidates As highlighted in our 2025 half-yearly results, IP Group has financial exposure to several of Metseras obesity drug programmes, following its acquisition of our former portfolio company Zihipp Limited in 2023
doi: 10.1016/s0024-3205(00)00803-1
CrossRef Gelsolin's Protective Role in MASH through FActin Regulation and P53 Degradation Yiwei Lu, Tong Ji, Zhichao Ye, Jianing Yan, Chao Wang, Jiachen Chen, Ziyang Jin, Yongji Zhu, Xiujun Cai, Yifan Wang Advanced Science .2025;[Epub] CrossRef Emerging therapies and real-world application of metabolic dysfunction-associated steatotic liver disease treatment Hee Yeon Kim, Mary E
Smiley Aesthetics is proud to partner with Strive Pharmacy, a licensed compounding pharmacy located at: PHARMACY ADDRESS 3906 Cragmont Drive Tampa, FL 33619 Phone: 813-644-7700 Fax: 813-644-7067 Email: [email protected] Strive Pharmacy adheres to strict quality standards and regulatory guidelines to ensure the safety and integrity of its formulations
Males with MS also exhibit more extensive whole brain and grey matter (GM) atrophy and ventricular enlargement compared to females indicating more extensive neuronal loss in males (911)
To further confirm its effects in this process, we modulated the expression of key regulators of ferroptosis in vitro